- Home
- PAC vs COO Comparison
PAC vs COO Comparison
Compare PAC & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- COO
- Stock Information
- Founded
- PAC 1998
- COO 1980
- Country
- PAC Mexico
- COO United States
- Employees
- PAC N/A
- COO N/A
- Industry
- PAC Aerospace
- COO Ophthalmic Goods
- Sector
- PAC Consumer Discretionary
- COO Health Care
- Exchange
- PAC Nasdaq
- COO Nasdaq
- Market Cap
- PAC 12.7B
- COO 14.6B
- IPO Year
- PAC 2006
- COO N/A
- Fundamental
- Price
- PAC $247.00
- COO $75.22
- Analyst Decision
- PAC Buy
- COO Buy
- Analyst Count
- PAC 6
- COO 9
- Target Price
- PAC $207.50
- COO $96.89
- AVG Volume (30 Days)
- PAC 75.4K
- COO 1.6M
- Earning Date
- PAC 10-20-2025
- COO 08-27-2025
- Dividend Yield
- PAC 4.55%
- COO N/A
- EPS Growth
- PAC 0.10
- COO 21.77
- EPS
- PAC 0.97
- COO 2.07
- Revenue
- PAC $1,748,047,047.00
- COO $3,988,200,000.00
- Revenue This Year
- PAC $59.91
- COO $6.84
- Revenue Next Year
- PAC $7.61
- COO $6.44
- P/E Ratio
- PAC $25.49
- COO $36.34
- Revenue Growth
- PAC 34.62
- COO 6.88
- 52 Week Low
- PAC $156.48
- COO $65.00
- 52 Week High
- PAC $256.22
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- PAC 61.28
- COO 59.85
- Support Level
- PAC $241.92
- COO $70.64
- Resistance Level
- PAC $256.22
- COO $74.36
- Average True Range (ATR)
- PAC 5.50
- COO 1.70
- MACD
- PAC 0.48
- COO 0.38
- Stochastic Oscillator
- PAC 66.89
- COO 95.70
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.